Drug discovery and development

Switching to biosimilars could save £1bn over five years, says NHS England

To facilitate cost savings, NHS England is considering making it a new service condition that NHS providers ensure the best-value biosimilar medicines are prescribed.…

Engineering precision: developing the next generation of antibody drug conjugates

Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…

Pharmacy professionals will be vital to the MHRA’s regulatory work in 2025

The chief executive of the Medicines and Healthcare products Regulatory Agency reviews the successes of 2024 in medicine regulation and looks at where improvements can be made in the year ahead.…

PDA begins fundraising for international campaign to send medicines to Gaza

The ‘Medicines to Gaza’ initiative was set up by the Pharmacists’ Defence Association to raise funds for medicines in Palestine.…

Approval of new NHS drugs results in population health ‘trade-offs’, study results suggest

Study authors concluded that the use of new drugs on the NHS resulted in an additional cost of more than £75bn between 2000 and 2020.…

How to evaluate the impact of a quality improvement intervention

Measurement is the only way to tell if a pharmacy quality improvement intervention has made an impact.…

How knowledge mobilisation led to the NASA team visiting the UCL School of Pharmacy 

In the ever-evolving landscape of scientific discovery and innovation, the concept of knowledge mobilisation has become vital for linking research to real-world impact. It involves actively sharing knowledge between communities to ensure that academic findings extend beyond laboratories and journal …

Pharmacy organisations sign up to ‘Medicines to Gaza’ campaign

Following on from the success of the ‘Medicines to Ukraine’ model, which raised £4.5m, the Pharmacists’ Defence Association announced the new Gaza scheme at the International Pharmaceutical Federation Congress in Cape Town on 3 September 2024.…

Pharmaceuticals from marine sources: past, present and future

An overview of why marine natural products are an attractive prospect for future drug discovery, including history of the field, successes in the clinic and challenges associated with gaining clinical approval.…

Clinical trial recruitment in England fell by almost 10% in 2023/2024

There were 18,140 people recruited to interventional industry clinical trials in 2023/2024, compared with 19,984 people in 2022/2023.…